Systemic chemotherapy with FOLFOX in metastatic grade 1/2 neuroendocrine cancer

Por Faure, Marjorie, Niccoli, Patricia, Autret, Aurelie, Cavaglione, Gerard, Mineur, Laurent, Raoul, Jean-Luc
Publicado no Mol Clin Oncol (2017)

Stereotactic Body radiation therapy for liver tumors with or without rotational intensity modulated radiation therapy

Por Nouhaud, Elodie, Créhange, Gilles, Cueff, Adèle, Quivrin, Magali, Rouffiac-Thouant, Magali, Mineur, Laurent, Garcia, Robin, Chamois, Jérôme, Maingon, Philippe
Publicado no BMC Res Notes (2013)

Skin toxicity and quality of life in patients with metastatic colorectal cancer during first-line panitumumab plus FOLFIRI treatment in a single-arm phase II study

Por Thaler, Josef, Karthaus, Meinolf, Mineur, Laurent, Greil, Richard, Letocha, Henry, Hofheinz, Ralf, Fernebro, Eva, Gamelin, Erick, Baños, Ana, Köhne, Claus-Henning
Publicado em 2012

Cetuximab Plus FOLFIRINOX (ERBIRINOX) as First-Line Treatment for Unresectable Metastatic Colorectal Cancer: A Phase II Trial

Por Assenat, Eric, Desseigne, Francoise, Thezenas, Simon, Viret, Frédéric, Mineur, Laurent, Kramar, Andrew, Samalin, Emmanuelle, Portales, Fabienne, Bibeau, Frédéric, Crapez-Lopez, Evelyne, Bleuse, Jean Pierre, Ychou, Marc
Publicado em 2011

Impact of tumour RAS/BRAF status in a first-line study of panitumumab + FOLFIRI in patients with metastatic colorectal cancer

Por Karthaus, Meinolf, Hofheinz, Ralf-Dieter, Mineur, Laurent, Letocha, Henry, Greil, Richard, Thaler, Josef, Fernebro, Eva, Oliner, Kelly S, Boedigheimer, Michael, Twomey, Brian, Zhang, Ying, Demonty, Gaston, Köhne, Claus-Henning
Publicado no Br J Cancer (2016)

Methylenetetrahydrofolate reductase (MTHFR) gene polymorphisms and FOLFOX response in colorectal cancer patients

Por Etienne-Grimaldi, Marie-Christine, Milano, Gérard, Maindrault-Gœbel, Frédérique, Chibaudel, Benoist, Formento, Jean-Louis, Francoual, Mireille, Lledo, Gérard, André, Thierry, Mabro, May, Mineur, Laurent, Flesch, Michel, Carola, Elisabeth, de Gramont, Aimery
Publicado em 2010

Panitumumab Use in Metastatic Colorectal Cancer and Patterns of KRAS Testing: Results from a Europe-Wide Physician Survey and Medical Records Review

Por Trojan, Jörg, Mineur, Laurent, Tomášek, Jiří, Rouleau, Etienne, Fabian, Pavel, de Maglio, Giovanna, García-Alfonso, Pilar, Aprile, Giuseppe, Taylor, Aliki, Kafatos, George, Downey, Gerald, Terwey, Jan-Henrik, van Krieken, J. Han
Publicado no PLoS One (2015)

Survival, safety, and prognostic factors for outcome with Regorafenib in patients with metastatic colorectal cancer refractory to standard therapies: results from a multicenter stu...

Por Adenis, Antoine, de la Fouchardiere, Christelle, Paule, Bernard, Burtin, Pascal, Tougeron, David, Wallet, Jennifer, Dourthe, Louis-Marie, Etienne, Pierre-Luc, Mineur, Laurent, Clisant, Stéphanie, Phelip, Jean-Marc, Kramar, Andrew, Andre, Thierry
Publicado no BMC Cancer (2016)

Erratum to: Survival, safety, and prognostic factors for outcome with Regorafenib in patients with metastatic colorectal cancer refractory to standard therapies: results from a mul...

Por Adenis, Antoine, de la Fouchardiere, Christelle, Paule, Bernard, Burtin, Pascal, Tougeron, David, Wallet, Jennifer, Dourthe, Louis-Marie, Etienne, Pierre-Luc, Mineur, Laurent, Clisant, Stéphanie, Phelip, Jean-Marc, Kramar, Andrew, Andre, Thierry
Publicado no BMC Cancer (2016)

Prognostic nomogram and score to predict overall survival in locally advanced untreated pancreatic cancer (PROLAP)

Por Vernerey, Dewi, Huguet, Florence, Vienot, Angélique, Goldstein, David, Paget-Bailly, Sophie, Van Laethem, Jean-Luc, Glimelius, Bengt, Artru, Pascal, Moore, Malcolm J, André, Thierry, Mineur, Laurent, Chibaudel, Benoist, Benetkiewicz, Magdalena, Louvet, Christophe, Hammel, Pascal, Bonnetain, Franck
Publicado no Br J Cancer (2016)